Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Ciruela, Francisco, Víctor Fernández-Dueñas, Fernando Contreras, Josep M. Arnau, José Manuel Menchón, Antoni Vallano, and Marta Valle-León. "Adenosine in the neurobiology of schizophrenia: potential adenosine receptor-based pharmacotherapy." In Psychiatry and Neuroscience Update, pp. 375-388. Springer, Cham, 2015. |
|
Posselt, Christine Merrild, Nikolai Albert, Merete Nordentoft, and Carsten Hjorthøj. "The Danish OPUS early intervention services for first-episode psychosis: a phase 4 prospective cohort study with comparison of randomized trial and real-world data." American Journal of Psychiatry 178, no. 10 (2021): 941-951. |
|
Langova, Veronika, Karel Vales, Petra Horka, and Jiri Horacek. "The role of zebrafish and laboratory rodents in schizophrenia research." Frontiers in Psychiatry 11 (2020). |
|
Goldstein, Karen M., Wei Duan-Porter, Aviel Alkon, Maren K. Olsen, Corrine I. Voils, and Susan N. Hastings. "Enrollment and retention of men and women in health services research and development trials." Women's Health Issues 29 (2019): S121-S130. |
|
Weintraub, Marc J., Jamie Zinberg, Carrie E. Bearden, and David J. Miklowitz. "Applying a transdiagnostic cognitive-behavioral treatment to adolescents at high risk for serious mental illness: rationale and preliminary findings." Cognitive and behavioral practice 27, no. 2 (2020): 202-214. |
|
Storbjörk, Jessica, Joshua BB Garfield, and Andrew Larner. "Implications of eligibility criteria on the generalizability of alcohol and drug treatment outcome research: A study of real-world treatment seekers in Sweden and in Australia." Substance use & misuse 52, no. 4 (2017): 439-450. |
|
Debrey, Sarah M., and David R. Goldsmith. "Tardive dyskinesia: spotlight on current approaches to treatment." Focus 19, no. 1 (2021): 14-23. |
|
Finnegan, M., and B. O’Donoghue. "Rethinking vulnerable groups in clinical research." Irish Journal of Psychological Medicine 36, no. 1 (2019): 63-71. |
|
Salmas, Ramin Ekhteiari, Philip Seeman, Matthias Stein, and Serdar Durdagi. "Structural investigation of the dopamine-2 receptor agonist bromocriptine binding to dimeric D2HighR and D2LowR states." Journal of chemical information and modeling 58, no. 4 (2018): 826-836. |
|
Wong, Jessie J., Nev Jones, Christine Timko, and Keith Humphreys. "Exclusion criteria and generalizability in bipolar disorder treatment trials." Contemporary clinical trials communications 9 (2018): 130-134. |
|
Meijer, Julia H., Peter van Harten, Carin J. Meijer, Maarten W. Koeter, Richard Bruggeman, Wiepke Cahn, René S. Kahn, L. de Haan, and Genetic Risk and Outcome of Psychosis (GROUP) Study. "Association between olfactory identification and parkinsonism in patients with non?affective psychosis." Early intervention in psychiatry 10, no. 5 (2016): 404-410. |
|
Blanco, Carlos, Nicolas Hoertel, Silvia Franco, Mark Olfson, Jian-Ping He, Saioa López, Ana González-Pinto, Frédéric Limosin, and Kathleen R. Merikangas. "Generalizability of clinical trial results for adolescent major depressive disorder." Pediatrics 140, no. 6 (2017). |
|
Trivedi, Ranak B., and Keith Humphreys. "Participant exclusion criteria in treatment research on neurological disorders: are unrepresentative study samples problematic?." Contemporary clinical trials 44 (2015): 20-25. |
|
Galan?Rodriguez, Beatriz, Elodie Martin, Emmanuel Brouillet, Nicole Déglon, Sandrine Betuing, and Jocelyne Caboche. "Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin." European Journal of Neuroscience 45, no. 1 (2017): 198-206. |
|
ShahMahmood, T. M., Zahra Ghayoumi-Anaraki, Abbas Ebadi, and Fatemeh Haresabadi. "Diagnostic Accuracy of the Photographic Expressive Persian Grammar Test to Identify 4-6 Years Old Children With Developmental Language Disorder." Iranian Rehabilitation Journal 18, no. 3 (2020): 345-353. |
|
Moberg, Christine A., and Keith Humphreys. "Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis." Drug and alcohol review 36, no. 3 (2017): 378-388. |
|
Dias, Flávia Regina Cruz, João Marcos de Mello Bastos, Maria de Fátima dos Santos Sampaio, Robert J. Carey, and Marinete Pinheiro Carrera. "Opposite effects of typical and atypical anti-psychotic drugs on sensitized dopamine receptors: Sub-chronic low dose Olanzapine exposure reverses sensitization but a similar regimen of low dose haloperidol potentiates sensitization effects." Psychopharmacology 230, no. 4 (2013): 579-588. |
|
Goldstein-Piekarski, A. N., L. M. Williams, and K. Humphreys. "A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders." Translational psychiatry 6, no. 6 (2016): e847-e847. |
|
Fajnerová, Iveta. "Spatial memory in humans and its disorders: From animal models towards schizophrenia." (2016). |
|
Mavrogiorgou, Paraskevi, Christian Kossmann, Sarah Irawan, Thomas Lücke, and Georg Juckel. "Psychiatrische Komorbidität beim Ullrich-Turner-Syndrom." Fortschritte der Neurologie· Psychiatrie 87, no. 05 (2019): 313-318. |
|